Marker Therapeutics (MRKR) vs Radiopharm Theranostics (RADX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Marker Therapeutics (MRKR) has outperformed Radiopharm Theranostics (RADX) over the past year, losing 1.9% versus a loss of 83.7%. Radiopharm Theranostics is the larger company by market cap ($16.2 million vs $15.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MRKR | RADX |
|---|---|---|
| Share price | $0.95 | $1.11 |
| Market cap | $15.84M | $16.20M |
| 1-day change | -8.65% | -3.48% |
| YTD return | -30.20% | -77.97% |
| 1-year return | -1.89% | -83.66% |
| 5-year return | -93.46% | — |
| EPS (TTM) | $-0.42 | $-3.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.46 | $16.25 |
| 52-week low | $0.84 | $1.00 |
| Distance from 52-week high | -61.38% | -93.17% |
| Average volume | 64.80K | 84.62K |
| Shares outstanding | 16.67M | 14.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- MRKR has outperformed RADX by 81.8 percentage points over the past year.
MRKR vs RADX FAQ
Which is bigger, Marker Therapeutics or Radiopharm Theranostics?
Radiopharm Theranostics (RADX) is larger, with a market capitalization of $16.20M compared with $15.84M for Marker Therapeutics (MRKR).
Which stock has performed better over the past year, MRKR or RADX?
MRKR returned -1.89% over the past 12 months, compared with -83.66% for RADX (price return, excluding dividends). Past performance does not predict future results.
Are Marker Therapeutics and Radiopharm Theranostics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.